D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Microsoft
MSFT
|
+$549M |
| 2 |
Tesla
TSLA
|
+$538M |
| 3 |
Pinduoduo
PDD
|
+$357M |
| 4 |
Intel
INTC
|
+$261M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$255M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$398M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$300M |
| 3 |
Procter & Gamble
PG
|
+$281M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 5 |
JPMorgan Chase
JPM
|
+$250M |
Sector Composition
| 1 | Technology | 20.4% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 11.45% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
SBA Communications
SBAC
$20.7B
| $21.4M | 0.02% |
76,415
+15,577
| +26% | +$4.37M |
|
477
TripAdvisor
TRIP
$2.05B
| $21.4M | 0.02% |
1,190,429
-706,196
| -37% | -$12.7M |
|
|
IRRX
478
DELISTED
Integrated Rail and Resources Acquisition Corp.
IRRX
| $21.4M | 0.02% |
2,077,923
| – | – |
|
479
JB Hunt Transport Services
JBHT
$13.6B
| $21.4M | 0.02% |
122,516
-40,413
| -25% | -$7.05M |
|
|
DICE
480
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $21.3M | 0.02% |
+682,934
| New | +$21.3M |
|
481
Northern Trust
NTRS
$24.6B
| $21.3M | 0.02% |
240,654
-34,845
| -13% | -$3.08M |
|
482
Rapid7
RPD
$1.32B
| $21.3M | 0.02% |
625,873
+21,226
| +4% | +$721K |
|
483
Choice Hotels
CHH
$5.26B
| $21.2M | 0.02% |
188,649
-53,672
| -22% | -$6.05M |
|
484
Arthur J. Gallagher & Co
AJG
$75.9B
| $21.2M | 0.02% |
112,511
+97,801
| +665% | +$18.4M |
|
485
United Rentals
URI
$61.6B
| $21.2M | 0.02% |
59,683
+43,988
| +280% | +$15.6M |
|
|
CVII
486
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $21.1M | 0.02% |
2,117,677
+1,142,245
| +117% | +$11.4M |
|
487
Waters Corp
WAT
$17.7B
| $21.1M | 0.02% |
61,575
+36,917
| +150% | +$12.6M |
|
488
Warner Bros
WBD
$30B
| $21M | 0.02% |
2,218,246
+1,133,294
| +104% | +$10.7M |
|
489
Kratos Defense & Security Solutions
KTOS
$11.2B
| $21M | 0.02% |
2,034,000
+702,270
| +53% | +$7.25M |
|
490
Innovative Industrial Properties
IIPR
$1.59B
| $21M | 0.02% |
206,896
-93,666
| -31% | -$9.49M |
|
491
Dollar Tree
DLTR
$20.2B
| $21M | 0.02% |
148,121
+134,195
| +964% | +$19M |
|
492
Fifth Third Bancorp
FITB
$30.2B
| $20.9M | 0.02% |
637,375
+461,682
| +263% | +$15.1M |
|
493
LivePerson
LPSN
$94.3M
| $20.9M | 0.02% |
2,060,951
+157,204
| +8% | +$1.59M |
|
494
Brinker International
EAT
$6.81B
| $20.8M | 0.02% |
650,919
+559,589
| +613% | +$17.9M |
|
495
Immunocore
IMCR
$1.83B
| $20.7M | 0.02% |
363,399
+230,897
| +174% | +$13.2M |
|
496
Booz Allen Hamilton
BAH
$12.7B
| $20.7M | 0.02% |
198,058
+177,173
| +848% | +$18.5M |
|
497
Ares Management
ARES
$39.4B
| $20.7M | 0.02% |
302,340
+90,213
| +43% | +$6.17M |
|
498
WillScot Mobile Mini Holdings
WSC
$4.23B
| $20.6M | 0.02% |
+456,937
| New | +$20.6M |
|
499
Maravai LifeSciences
MRVI
$385M
| $20.6M | 0.02% |
1,438,704
+621,160
| +76% | +$8.89M |
|
500
BridgeBio Pharma
BBIO
$10.2B
| $20.6M | 0.02% |
2,700,824
+342,755
| +15% | +$2.61M |
|